IFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024

PR Newswire09-26

NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2470473934?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TTYW6sM1h0_jcdDA5nL22g--~B/aD0xNzE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/96e9cac1e79c3db94b8d266500339a7f","is_english":true,"pubTime":"2024-09-26 21:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2470473934","market":"us","top_or_hot":-1,"title":"IFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024","media":"PR Newswire","content":"<div>\n<p>NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for ...</p>\n\n<a href=\"https://finance.yahoo.com/news/iff-pharma-solutions-brings-innovations-130000437.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-26 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/iff-pharma-solutions-brings-innovations-130000437.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for ...</p>\n\n<a href=\"https://finance.yahoo.com/news/iff-pharma-solutions-brings-innovations-130000437.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://finance.yahoo.com/news/iff-pharma-solutions-brings-innovations-130000437.html","article_id":"2470473934","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TTYW6sM1h0_jcdDA5nL22g--~B/aD0xNzE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/96e9cac1e79c3db94b8d266500339a7f"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/iff-pharma-solutions-brings-innovations-130000437.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2470473934","pubTimestamp":1727355600,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF  Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development.\"We are unveiling groundbreaking technologies that refine polymer expertise, tackling critical industry challenges head-on and empowering our customers to achieve unparalleled success,\" said Angela Strzelecki, President, Pharma Solutions, IFF. \"As we mark over 75 years of market leadership as a market leading excipient manufacturer, we invite visitors to join us to witness this transformative journey with us.\". In addition to its biopolymer solutions, IFF will introduce new fo","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4504":"桥水持仓","BK4007":"制药","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","BK4080":"零售业房地产投资信托","BK4109":"特种化学制品","BK4231":"零售房地产信托","IFF":"国际香料香精","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4561":"索罗斯持仓","WSR":"Whitestone REIT","CPHI":"惠普森医药"},"translate_title":"IFF Pharma Solutions为CPHI 2024带来新的创新和卓越的辅料","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CPHI":1,"IFF":1,"WSR":1},"content_text":"NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development.\n\n  \n\n\"We are unveiling groundbreaking technologies that refine polymer expertise, tackling critical industry challenges head-on and empowering our customers to achieve unparalleled success,\" said Angela Strzelecki, President, Pharma Solutions, IFF. \"As we mark over 75 years of market leadership as a market leading excipient manufacturer, we invite visitors to join us to witness this transformative journey with us.\"\nLow nitrite excipient solutions \nNitrosamine risk mitigation will take center stage at booth 6B10, where IFF will unveil its expanding portfolio of solutions for nitrosamine control. Avicel® PH Low Nitrite (LN) is a range of low nitrite microcrystalline cellulose (MCC) grades demonstrated to reduce the risk of nitrosamine formation as part of broader mitigation strategies. IFF's expertise in this space also extends to its well-established METHOCEL™ family of products. The Company will spotlight how its advanced analytical method leverages highly sensitive ion chromatography-mass spectrometry (IC/MS) to detect nitrites at trace levels down to parts per billion (ppb) in its METHOCEL™ grades. Furthermore, attendees can look forward to an exclusive preview of IFF's upcoming low nitrite addition.\nSupporting breakthroughs in biotech \nDemonstrating its contribution to the future of biotechnology, IFF will present its expanding ultrapure alginate technologies at CPHI. NOVAMATRIX-3D™, part of the NovaMatrix® product portfolio, is an animal-free 3D cell culture system engineered for efficient cell seeding and enzyme-free cell release. It offers a more physiologically relevant environment than traditional 2D cultures, supporting various cell lines and opening new possibilities for drug development, cancer research, tissue engineering, toxicity testing and stem cell research. IFF will also showcase PRONOVA® UP CAM, a specialized ultrapure calcium alginate allowing for controlled and in-situ gelation across diverse biomedical applications, from cell and drug encapsulation systems to advanced wound dressings and tissue engineering. \nNew horizons with POLYOX™ ES packaging \nIn addition to its biopolymer solutions, IFF will introduce new foil bag-in-box packaging for its POLYOX™ water-soluble resins (WSR). The packaging extends the stability of POLYOX™ WSR by providing a moisture and oxygen barrier to preserve polymer viscosity, improving the product's storage life and supporting more effective supply chain and inventory management practices. The packaging is also more easily recyclable than fiber drums providing more than 85 percent reduction in landfill waste associated with POLYOX™ WSR packaging to support customers' sustainability initiatives.\nJoin IFF's experts to learn how the Company's expanding capabilities continue to optimize drug product formulation and drive innovation forward, visit booth 6B10 or schedule an appointment here.\nWelcome to IFF\nAt IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, X (Twitter) , Facebook, Instagram, and LinkedIn.\n©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with TM, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.\nSOURCE IFF","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2470473934"}